Food and Drug Administration first approved Trulicity as a treatment for Type 2 diabetes
It mimics the effects of glucagon-like peptide-1 (GLP-1), which is responsible for regulating the production of insulin and glucagon
The adjustment is calculated based on the number of beneficiaries an ACO serves who are either enrolled in the LIS program or are dually eligible for Medicare and Medicaid, offering a targeted mechanism to reflect the needs of higher-risk populations
However, restarting often requires rebuilding tolerance to the medication, which may include an adjustment period similar to your initial treatment
(2021), the findings suggested that weight loss did not reduce lymphedema risk
Thus, clinical trials can be conducted using topical or oral routes of administration to avoid high systemic exposure to the drug or compound under investigation [127]